|
40 |
How much air does a cleanroom need?
|
sureAssist |
2024-12-26 |
747 |
|
39 |
Risk Tool Selection With ICH Q9(R1) In Mind
|
sureAssist |
2024-12-26 |
801 |
|
38 |
FDA issues draft guidance on post-warning letter meetings under GDUFA III
|
sureAssist |
2024-12-26 |
704 |
|
37 |
5 Best Practices For Responding To FDA Form 483 Inspection Observations
|
sureAssist |
2024-12-26 |
1,833 |
|
36 |
Cleanrooms: solving the mystery of recurring low level contamination
|
sureAssist |
2024-12-26 |
659 |
|
35 |
The possible Impact of Artificial Intelligence on the Role of the Qualified Person
|
sureAssist |
2024-12-26 |
687 |
|
34 |
Preparing A framework For Artificial Intelligence And Machine Learning Validation: A 3-Step Approach
|
sureAssist |
2024-12-26 |
847 |
|
33 |
CGMP Requirements For Automated Facility Monitoring Systems
|
sureAssist |
2024-12-26 |
722 |
|
32 |
RTU vs concentrate disinfectants: efficiency as a factor in selection
|
sureAssist |
2024-12-26 |
732 |
|
31 |
EMA phases out extraordinary COVID-19 regulatory flexibilities
|
sureAssist |
2024-12-26 |
702 |
